NEURIX
LIVE

Serial Number

79122976

Owner

Neurix SA

Filing Date

Oct 16, 2012

Add to watchlist:

No watchlists yet
View on USPTO

NEURIX Trademark

Serial Number: 79122976 • Registration: 4690255

NEURIX is a trademark filed by Neurix SA on October 16, 2012. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Neurix SA (2 trademarks)

64 Avenue de la Roseraie

Entity Type: 99

Trademark Details

Filing Date

October 16, 2012

Registration Date

February 24, 2015

Published for Opposition

December 9, 2014

Cancellation Date

October 17, 2022

Goods & Services

Pharmaceutical products unrelated to dietary food supplements, namely, preparations of human or non-human cells, cell parts or generated biogenic and released chemical substances for medical diagnosis, prevention, therapy and predictive medicine, for drug efficacy assessment as well as for toxicity testing of chemical and biological compounds, and veterinary products unrelated to dietary food supplements, namely, preparations of non-human cells, cell parts or generated biogenic and released chemical substances for non-livestock cell replacement therapy excluding antibacterial properties; medical preparations for sanitary use, namely, preparations related to human or non-human cells, cell parts or generated biogenic and released chemical substances; medical plasters, materials for medical dressings, namely, preparations of human or non-human cells, cell parts or generated biogenic and released chemical substances; material for dental filings and dental impressions, namely, preparations of human or non-human cells, cell parts or generated biogenic and released chemical substances; disinfectants for wounds, namely, preparations of human or non-human cells, cell parts or generated biogenic and released chemical substances; pesticides, excluding insecticides, generated by engineered cells; fungicides and herbicides generated by engineered cells

Medical services; veterinary services; non-food hygienic and beauty care for human beings or animals; agriculture services, namely, providing agricultural advice based on toxicity tests and impact studies of chemical and biological compounds or plants and plant elements; horticulture services; forestry services, namely, providing forestry advice based on toxicity tests and impact studies of chemical and biological compounds or plants and plant elements

Surgical apparatus and instruments, medical apparatus and instruments for preparation, injection, engraftment or use of human or non-human cells, cell parts or generated biogenic and released chemical substances that are designed for medical diagnosis, prevention, therapy and predictive medicine, for drug efficacy assessment as well as for toxicity testing of chemical and biological compounds; dental apparatus and instruments for use in preparing, injecting and engrafting human or non-human cells, cell parts or generated biogenic and released chemical substances; veterinary apparatus and instruments for preparation, injection, engraftment or use of non-human cells, cell parts or generated biogenic and released chemical substances that are designed for veterinary diagnosis, prevention, therapy and predictive medicine, for drug efficacy assessment as well as for toxicity testing of chemical and biological compounds; artificial limbs, eyes and teeth; orthopedic articles for preventive and therapeutic use; suture materials

Scientific and technological services, namely, drug efficacy assessment, toxicity testing of chemical and biological compounds, development and quality control of human or non-human cells, cell parts or generated biogenic and released chemical substances for medical diagnosis, prevention, therapy, predictive medicine and research and design relating thereto; industrial analysis and research services in the fields of drug efficacy assessment, toxicity testing of chemical and biological compounds, development, and quality control of human or non-human cells, cell parts or generated biogenic and released chemical substances for medical diagnosis, prevention, therapy and predictive medicine; design and development of computers and software

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 8, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 8, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 28, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 5, 2022 INTS
INVALIDATION PROCESSED
Aug 4, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 10, 2022 INTR
CANCELLED SECTION 71
Sep 10, 2021 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 4, 2020 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 24, 2020 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 31, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 1, 2015 FICS
FINAL DISPOSITION PROCESSED
Jul 1, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 24, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 24, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2014 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Dec 5, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 19, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 19, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 5, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2014 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 20, 2014 RCCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 2, 2014 ADCH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 20, 2014 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 4, 2014 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 4, 2014 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 9, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 9, 2014 GNSL
SUSPENSION LETTER WRITTEN
Apr 9, 2014 CNSL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 18, 2014 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 18, 2014 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2014 TROA
NON-FINAL ACTION MAILED
Sep 19, 2013 CNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2013 CRFA
ASSIGNED TO LIE
Aug 16, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2013 TROA
REFUSAL PROCESSED BY IB
Mar 10, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 15, 2013 RFCS
REFUSAL PROCESSED BY MPU
Feb 15, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 15, 2013 RFCR
NON-FINAL ACTION WRITTEN
Feb 14, 2013 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 15, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 7, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 3, 2013 REPR